Dual versus triple therapy in treatment of hepatitis C virus (HCV)

被引：0
作者：
Nevine Bishai
Walid el Nabawy
Mohamed El Fiki
Mohamed Ibrahim
Nouman El Garem
机构：
[1] Cairo University Hospitals,Department of Internal Medicine, Faculty of Medicine
[2] Beni-Sueif University Hospitals,Faculty of Medicine
[3] Cairo University Hospitals,Faculty of Medicine
来源：
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷 / 3期
关键词：
Daclatasvir; Egypt; HCV; Interferon; Ribavirin; Sofosbuvir; SVR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1129 / 1135
页数：6
相关论文
共 50 条
  • [1] Dual versus triple therapy in treatment of hepatitis C virus (HCV)
    Bishai, Nevine
    El Nabawy, Walid
    El Fiki, Mohamed
    Ibrahim, Mohamed
    El Garem, Nouman
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1129 - 1135
  • [2] The future of dual therapy for hepatitis C virus
    Azzaroli, Francesco
    Montagnani, Marco
    Porro, Alberto
    Fiorillo, Domenico
    Mazzella, Giuseppe
    FUTURE VIROLOGY, 2014, 9 (10) : 905 - 912
  • [3] Sofosbuvir-/Daclatasvir-based therapy for chronic HCV and HCV/hepatitis B virus coinfected patients in Egypt
    Nagaty, Ahmed
    Helmy, Sherine H. A.
    Abd El-Wahab, Ekram W.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2020, 114 (03) : 200 - 212
  • [4] Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus (HCV) patients
    Abd Elaziz, Mohamed Samy
    Nada, Ali Saad Eldeen
    ElSayed, Saber Hamid
    Nasr, Ghada Salah
    Zaky, Adel Galal
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (05) : 1245 - 1251
  • [5] Treatment of hepatitis C virus infection
    Parlati, Lucia
    Hollande, Clemence
    Pol, Stanislas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [6] Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus (HCV) patients
    Mohamed Samy Abd Elaziz
    Ali Saad Eldeen Nada
    Saber Hamid ElSayed
    Ghada Salah Nasr
    Adel Galal Zaky
    International Ophthalmology, 2020, 40 : 1245 - 1251
  • [7] Daclatasvir for the treatment of hepatitis C virus infection
    Adler, Hugh
    Lambert, John S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 725 - 738
  • [8] Predictors of Treatment for Hepatitis C Virus (HCV) Infection in Drug Users
    Reed, Carrie
    Stuver, Sherri O.
    Tumilty, Sheila
    Nunes, David
    Murray, Jessica E.
    Graham, Camilla S.
    Koziel, Margaret James
    Craven, Donald E.
    Skolnik, Paul R.
    Horsburgh, C. Robert, Jr.
    SUBSTANCE ABUSE, 2008, 29 (01) : 5 - 15
  • [9] Hepatitis C Virus Therapy for Decompensated and Posttransplant Patients
    Dailey, Francis
    Ayoub, Walid S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2017, 51 (03) : 215 - 222
  • [10] Very late HCV relapse following triple therapy for hepatitis C
    Barreiro, Pablo
    Vispo, Eugenia
    Maida, Ivana
    Aguilera, Antonio
    Fernandez-Montero, Jose V.
    de Mendoza, Carmen
    Labarga, Pablo
    Soriano, Vincent
    ANTIVIRAL THERAPY, 2014, 19 (07) : 723 - 724
12345